安捷伦与马来西亚莫纳什大学共建生物发现中心 - 医药科技
Agilent and Monash University Malaysia to set up biodiscovery hub - Pharmaceutical Technology
生命科学资讯
生物技术与制药领域的最新动态
安联投资增持沃特世公司股份 $WAT - MarketBeat
Amundi Raises Position in Waters Corporation $WAT - MarketBeat
Microsize通过大胆进军欧洲微粉化领域扩大全球版图 - MyChesCo
Microsize Expands Global Footprint With Bold Move Into European Micronization - MyChesCo
KeyBanc将赛默飞世尔科技股票评级上调至增持，目标价750美元 - Investing.com
KeyBanc upgrades Thermo Fisher Scientific stock rating to Overweight with $750 target - Investing.com
生命科学工具与服务类股票第三季度财报：10x Genomics（纳斯达克代码：TXG）全面发力 - 雅虎财经
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Yahoo Finance
生命科学工具与服务类股第三季度财报：10x Genomics (NASDAQ:TXG) 全面发力 - TradingView
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - TradingView
生命科学工具与服务股第三季度财报：10x Genomics (NASDAQ:TXG) 全面发力 - 市场财经资讯
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Markets Financial Content
沃特世公司将在Citi 2013全球医疗保健大会上进行演示，并通过AOL.com进行网络直播。
Waters Corporation Presentation at the Citi 2013 Global Healthcare Conference to Be Webcast Live - AOL.com
单一免疫原上展示多种血凝素亚型的模块化平台
A modular platform to display multiple hemagglutinin subtypes on a single immunogen
深度学习揭示内源性甾醇作为GPCR-Gα界面的变构调节剂
Deep learning reveals endogenous sterols as allosteric modulators of the GPCR–Gα interface
听觉皮层中共同调谐集合活动的快速再平衡
Rapid rebalancing of co-tuned ensemble activity in the auditory cortex
肌动蛋白细胞骨架中致密向列结构的主动自组织理论
Theory of active self-organization of dense nematic structures in the actin cytoskeleton
小鼠胚胎极化异步导致细胞命运指定异质性
Asynchronous mouse embryo polarization leads to heterogeneity in cell fate specification
PPARγ介导的脂质生物合成增强，在药物耐受性肝细胞环境中促进结核分枝杆菌生长。
PPARγ mediated enhanced lipid biogenesis fuels Mycobacterium tuberculosis growth in a drug-tolerant hepatocyte environment
危险病原体的意外新藏身之处
A surprising new hiding place for a dangerous pathogen
#ASH25：Star Therapeutics公布血液疾病注射剂早期数据，并考虑IPO。
#ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO
龙沙集团增长倚重生物制剂，但风险犹存——Finimize
Lonza’s Growth Hinges On Biologics, But Risks Remain - Finimize
ASH：随着吉利德旗下Kite公司准备上市，Anito-cel强化了其最佳潜力。
ASH: Anito-cel strengthens best-in-class potential as Gilead's Kite preps for launch
在ASH大会上，礼来力推Jaypirca在白血病和淋巴瘤中的更广泛应用。
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
ASH：明星抗体在潜在三期出血性疾病成功预演中闪耀。
ASH: Star antibody sparkles in preview of potential phase 3 bleeding disease success